SUBSCRIBE
SUBSCRIBE
News   Business

FDA’s No. 2 Deputy Commissioner Sharfstein to Resign

January 5, 2011 | 
1 min read
WSJ -- The Food and Drug Administration's No. 2 official is leaving the agency after a busy 21-month tenure that included clashes with drug and device makers over tougher regulation.
People
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Richard Pazdur
Government
‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements
February 16, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman on a crossroad. Man choosing career. Searching of right path. Decision and brainstorming concept. Flat vector illustration.
Earnings
Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation
February 13, 2026
 · 
5 min read
 · 
Annalee Armstrong
Adult people customers group in casual clothes standing in long line queue
Gene therapy
Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp
February 13, 2026
 · 
3 min read
 · 
Dan Samorodnitsky
Various white pills and capsules forming a map of the world, illustrating humanity's increasing dependency on medication manufacturing.
Obesity
Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas
February 13, 2026
 · 
2 min read
 · 
Tristan Manalac